x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Neuro-Oncology: The Podcast

Neuro-Oncology: The Podcast will keep you up to date about the latest advances in the field as we present conversations with the authors of selected papers from Neuro-Oncology and its sister journals, Neuro-Oncology Practice and Neuro-Oncology Advances.

health & fitness medicine

All Episodes

16:05

Radiotherapy induced neurocognitive decline

Neuro-Oncology: The Podcast ·

2025/10/24

Description: Dr. Iyad Alnahhas interviews Dr. Charlotte Sleurs about her and her team's recent manuscript entitled: "Radiotherapy-induced neurocognitive decline among adult intracranial tumor patients: A voxel-based approach", published online in Neuro-Oncology in May 2025.

en

18:22

QOL and cognitive functioning in patients with...

Neuro-Oncology: The Podcast ·

2025/09/26

Dr. Iyad Alnahhas interviews Drs. Florien Boele and Martin Klein about their recent manuscript entitled: “Health-related quality of life and cognitive functioning in survivors of oligodendroglioma: An international cross-sectional investigation”, published online in Neuro-Oncology in July 2025.

en

19:39

Post-operative radiation in recurrent grade 1...

Neuro-Oncology: The Podcast ·

2025/09/12

Dr. Iyad Alnahhas interviews Drs. Felix Sahm and Maximilian Deng about their recent manuscript entitled: "Postoperative radiotherapy in subtotally-resected recurrent WHO grade 1 meningiomas with intermediate/ high-risk molecular profiles", published online in Neuro-Oncology in May 2025.

en

29:43

mRNA CAR T against GD2 in high-grade glioma models

Neuro-Oncology: The Podcast ·

2025/08/29

Dr. Maya Graham interviews Dr. Jessica Foster about her and her team's recent manuscript, entitled "Transient mRNA CAR T cells targeting GD2 provide dose-adjusted efficacy against diffuse midline glioma and high-grade glioma models". This work was published online in Neuro-Oncology in May 2025.

en

35:22

A transcriptomic atlas of CNS tumors

Neuro-Oncology: The Podcast ·

2025/07/11

Dr. Evan Noch interviews Dr. Akshitkumar Mistry about his and his team's recent manuscript entitled "A clinically annotated transcriptomic atlas of nervous system tumors", published online in Neuro-Oncology in May 2025 Link to the paper: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf130/8151442

en

15:04

Gut microbiome in primary CNS lymphoma

Neuro-Oncology: The Podcast ·

2025/06/27

Dr. Iyad Alnahhas interviews Drs. Isaias Hernandez-Verdin and Agusti Alentorn about their recent manuscript entitled: "Gut microbiome modulates the outcome in primary central nervous system lymphoma patients undergoing chemotherapy: An ancillary study from the BLOCAGE trial", published online in Neuro-Oncology in March 2025 Link: https://academic.oup.com/neuro-oncology/advance-article/doi/10.1093/neuonc/noaf059/8058778

en

29:55

Germline analysis of diffuse midline glioma

Neuro-Oncology: The Podcast ·

2025/06/08

Dr. Evan Noch interviews Dr. Marion Mateos about her and her team's recent manuscript entitled: "Germline analysis of an international cohort of pediatric diffuse midline glioma patients", published online in Neuro-Oncology in March 2025.

en

22:05

Passion Flower for Sleep and Calming

Neuro-Oncology: The Podcast ·

2025/05/21

Passion Flower for Sleep and Calming Passion Flower is well-known historically for its calming properties. The “amount” of calming depends on the dose (see below). You can take Passion Flower during the day and during the night, with or without food. Try it before business meetings, when anxious, before bed AND during the night if you wake up and your mind is busy. It helps calm pain, anxiety and can help menstrual cramps too. More Information

en

16:55

The proteomic landscape of diffuse midline glioma

Neuro-Oncology: The Podcast ·

2025/05/17

Dr. Iyad Alnahhas interviews Drs. Cynthia Hawkins and Arun Vadivel about their recent manuscript entitled: "The proteomic landscape of diffuse midline glioma highlights the therapeutic potential of non-histone protein methyltransferases", published online in Neuro-Oncology in February 2025. More Information

en

20:25

Radio-Pathomic maps and MR perfusion

Neuro-Oncology: The Podcast ·

2025/04/18

Dr. Iyad Alnahhas interviews Dr. Peter LaViolette about his and his team's recent manuscript entitled: "Multi-Site Retrospective Analysis of Diffusion and Perfusion MRI Correlates to Glioma Characteristics Derived from Radio-Pathomic Maps", published online in Neuro-Oncology in February 2025.

en

44:15

CSF proteomics in glioma

Neuro-Oncology: The Podcast ·

2025/03/21

Description: Dr. Evan Noch interviews Drs. Cecile Riviere-Cazaux and Terry Burns about their recent manuscript entitled: "A field resource for the glioma cerebrospinal fluid proteome: impacts of resection and location on biomarker discovery", published online in Neuro-Oncology in December 2024. Link: https://doi.org/10.1093/neuonc/noae277

en

42:44

Vorasidenib in IDH mutant glioma

Neuro-Oncology: The Podcast ·

2025/03/08

Description: Dr. Ankush Bhatia interviews Drs. Macarena de la Fuente and Mehdi Touat about their recent manuscript entitled: "The role of vorasidenib in the treatment of isocitrate dehydrogenase-mutant glioma" published online in Neuro-Oncology in December 2024. Link: https://doi.org/10.1093/neuonc/noae259

en

21:33

KL-50 in post TMZ MMR-deficient GBM

Neuro-Oncology: The Podcast ·

2025/02/22

Dr. Iyad Alnahhas interviews Dr. Craig Horbinski about his and his team's recent manuscript entitled "The novel DNA cross-linking agent KL-50 is active against patient-derived models of new and recurrent post-temozolomide mismatch repair-deficient glioblastoma", published online in Neuro-Oncology in December 2024.

en

14:06

Measurable disease per FET-PET vs MRI in GBM

Neuro-Oncology: The Podcast ·

2025/02/08

Dr. Iyad Alnahhas interviews Dr. Nathalie Albert about her and her team's recent manuscript entitled: "Measurable disease as baseline criterion for response in glioblastoma: A comparison of PET-based (PET RANO 1.0) and MRI-based (RANO) assessments", published online in Neuro-Oncology in January 2025.

en

13:42

Pre-radiation chemotherapy in GBM

Neuro-Oncology: The Podcast ·

2025/01/20

Dr. Iyad Alnahhas interviews Dr. Danielle Bazer about her and her team's recently published manuscript, entitled: Using a Pre-Radiation Window to Identify Potentially Active Cytotoxic Agents in Adults with Newly Diagnosed Glioblastoma", published online in Neuro-Oncology in November 2024.

en

43:16

cIMPACT-NOW Update 8: grading of meningiomas

Neuro-Oncology: The Podcast ·

2024/12/13

Dr. Rachna Malani interviews Drs. Felix Sahm and Arie Perry about their recent manuscript entitled: "cIMPACT-NOW Update 8: Clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas", published online in Neuro-Oncology in August 2024 Read More

en

13:18

Residual tumor volume and survival after CCNU/TMZ in GBM

Neuro-Oncology: The Podcast ·

2024/11/24

Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

en

33:46

Alterations in RNA splicing between meningioma DNA...

Neuro-Oncology: The Podcast ·

2024/11/08

Dr. Evan Noch interviews Drs. Nathan Leclair, David Raleigh and Olga Anczukow about their recent manuscript entitled: "RNA splicing as a biomarker and phenotypic driver of meningioma DNA methylation groups", published online in Neuro-Oncology in August 2024.

en

33:27

The immune landscape of IDH mutant and IDHwt glioma

Neuro-Oncology: The Podcast ·

2024/10/25

Dr. Evan Noch interviews Drs. Pravesh Gupta and Krishna Bhat about their recent manuscript entitled "Immune landscape of isocitrate dehydrogenase-stratified primary and recurrent human gliomas", published online in Neuro-Oncology in August 2024 Read Paper

en

22:34

Equity-driven applications of AI in neuro-oncology

Neuro-Oncology: The Podcast ·

2024/10/09

Dr. Iyad Alnahhas interviews Dr. Mulki Mehari about her and her team's recent manuscript entitled: "Enhancing neuro-oncology care through equity-driven applications of artificial intelligence", published online in Neuro-Oncology in August 2024.

en

109 results

Similar Podcasts

Доктор Тройняшкин

Доктор Тройняшкин

The Dry Eye Treatment PODCAST

Dry Eye Treatment

Différent et alors ?

PATRICK SULAY

Kyle Kingsbury Podcast

Kyle Kingsbury

The Real Weight Loss Coach

Matty Lansdown